AU Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals Ltd

Watchlist
  • 24.530
  • +0.420+1.74%
20min DelayMarket Closed Dec 13 16:00 AET
8.21BMarket Cap1533.13P/E (Static)

Telix Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
(FY)Dec 30, 2020
(FY)Dec 30, 2019
(FY)Dec 30, 2018
(FY)Dec 30, 2017
Operating cash flow (direct method)
Cash income from operating activities
212.84%447.37M
778.35%143M
-66.04%16.28M
277.87%47.94M
977.34%12.69M
154.85%1.18M
462.13K
Revenue from customers
273.63%463.65M
2,884.49%124.1M
-88.62%4.16M
966.21%36.54M
--3.43M
----
----
Other cash income from operating activities
-186.11%-16.28M
55.98%18.91M
6.30%12.12M
23.15%11.41M
686.35%9.26M
154.85%1.18M
--462.13K
Cash paid
-102.42%-414.08M
-171.24%-204.57M
-64.46%-75.42M
-27.38%-45.86M
-61.86%-36M
-241.03%-22.24M
-6.52M
Payments to suppliers for goods and services
-102.42%-414.08M
-171.24%-204.57M
-64.46%-75.42M
-27.38%-45.86M
-61.86%-36M
-241.03%-22.24M
---6.52M
Direct interest paid
-499.24%-785K
30.69%-131K
1.05%-189K
-63.25%-191K
-583.69%-117K
-222.83%-17.11K
---5.3K
Direct interest received
162,800.00%1.63M
--1K
----
-31.63%67K
-70.55%98K
882.79%332.73K
--33.86K
Direct tax refund paid
-350.09%-10.25M
---2.28M
----
----
----
----
----
Operating cash flow
137.34%23.88M
-7.82%-63.97M
-3,126.94%-59.33M
108.40%1.96M
-12.45%-23.33M
-244.01%-20.75M
---6.03M
Investing cash flow
Cash flow from continuing investing activities
-49.96%-25.49M
-523.51%-17M
-149.86%-2.73M
-133.12%-1.09M
82.62%-468K
-213,640.08%-2.69M
-1.26K
Net PPE purchase and sale
-37.52%-9.68M
-425.62%-7.04M
-439.92%-1.34M
38.46%-248K
---403K
----
---5.64K
Net intangibles purchas and sale
83.66%-1.12M
---6.82M
----
-13.85%-74K
---65K
----
----
Net business purchase and sale
----
---973K
----
---322K
----
-61,558.81%-2.69M
--4.38K
Net investment purchase and sale
---13.16M
----
----
----
----
----
----
Net other investing changes
28.80%-1.54M
-55.95%-2.16M
-210.29%-1.39M
---447K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-49.96%-25.49M
-523.51%-17M
-149.86%-2.73M
-133.12%-1.09M
82.62%-468K
-213,640.08%-2.69M
---1.26K
Financing cash flow
Cash flow from continuing financing activities
-94.18%10.19M
6,047.58%174.96M
-91.66%2.85M
-20.14%34.12M
5,014.34%42.72M
-101.59%-869.35K
54.79M
Net issuance payments of debt
91.80%5.76M
982.65%3M
15.42%-340K
57.37%-402K
-8.47%-943K
-13.02%-869.35K
---769.18K
Net common stock issuance
-96.16%6.65M
4,480.20%173.22M
-89.20%3.78M
-22.61%35.02M
--45.25M
----
--55.56M
Net other financing activities
-75.79%-2.22M
-112.08%-1.26M
-18.73%-596K
68.39%-502K
---1.59M
----
----
Cash from discontinued financing activities
Financing cash flow
-94.18%10.19M
6,047.58%174.96M
-91.66%2.85M
-20.14%34.12M
5,014.34%42.72M
-101.59%-869.35K
--54.79M
Net cash flow
Beginning cash position
427.88%116.33M
-71.73%22.04M
74.77%77.95M
73.05%44.6M
-47.15%25.77M
--48.76M
----
Current changes in cash
-90.87%8.58M
258.75%93.99M
-269.23%-59.21M
84.90%34.99M
177.83%18.92M
-149.86%-24.31M
--48.76M
Effect of exchange rate changes
-659.53%-1.67M
-90.94%299K
301.34%3.3M
-1,625.26%-1.64M
-107.18%-95K
--1.32M
----
Cash adjustments other than cash changes
----
----
----
----
----
--1.48K
----
End cash Position
5.94%123.24M
427.88%116.33M
-71.73%22.04M
74.77%77.95M
73.05%44.6M
-47.15%25.77M
--48.76M
Free cash from
116.82%13.09M
-28.29%-77.83M
-3,803.72%-60.67M
106.88%1.64M
-14.71%-23.8M
-243.69%-20.75M
---6.04M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021(FY)Dec 30, 2020(FY)Dec 30, 2019(FY)Dec 30, 2018(FY)Dec 30, 2017
Operating cash flow (direct method)
Cash income from operating activities 212.84%447.37M778.35%143M-66.04%16.28M277.87%47.94M977.34%12.69M154.85%1.18M462.13K
Revenue from customers 273.63%463.65M2,884.49%124.1M-88.62%4.16M966.21%36.54M--3.43M--------
Other cash income from operating activities -186.11%-16.28M55.98%18.91M6.30%12.12M23.15%11.41M686.35%9.26M154.85%1.18M--462.13K
Cash paid -102.42%-414.08M-171.24%-204.57M-64.46%-75.42M-27.38%-45.86M-61.86%-36M-241.03%-22.24M-6.52M
Payments to suppliers for goods and services -102.42%-414.08M-171.24%-204.57M-64.46%-75.42M-27.38%-45.86M-61.86%-36M-241.03%-22.24M---6.52M
Direct interest paid -499.24%-785K30.69%-131K1.05%-189K-63.25%-191K-583.69%-117K-222.83%-17.11K---5.3K
Direct interest received 162,800.00%1.63M--1K-----31.63%67K-70.55%98K882.79%332.73K--33.86K
Direct tax refund paid -350.09%-10.25M---2.28M--------------------
Operating cash flow 137.34%23.88M-7.82%-63.97M-3,126.94%-59.33M108.40%1.96M-12.45%-23.33M-244.01%-20.75M---6.03M
Investing cash flow
Cash flow from continuing investing activities -49.96%-25.49M-523.51%-17M-149.86%-2.73M-133.12%-1.09M82.62%-468K-213,640.08%-2.69M-1.26K
Net PPE purchase and sale -37.52%-9.68M-425.62%-7.04M-439.92%-1.34M38.46%-248K---403K-------5.64K
Net intangibles purchas and sale 83.66%-1.12M---6.82M-----13.85%-74K---65K--------
Net business purchase and sale -------973K-------322K-----61,558.81%-2.69M--4.38K
Net investment purchase and sale ---13.16M------------------------
Net other investing changes 28.80%-1.54M-55.95%-2.16M-210.29%-1.39M---447K------------
Cash from discontinued investing activities
Investing cash flow -49.96%-25.49M-523.51%-17M-149.86%-2.73M-133.12%-1.09M82.62%-468K-213,640.08%-2.69M---1.26K
Financing cash flow
Cash flow from continuing financing activities -94.18%10.19M6,047.58%174.96M-91.66%2.85M-20.14%34.12M5,014.34%42.72M-101.59%-869.35K54.79M
Net issuance payments of debt 91.80%5.76M982.65%3M15.42%-340K57.37%-402K-8.47%-943K-13.02%-869.35K---769.18K
Net common stock issuance -96.16%6.65M4,480.20%173.22M-89.20%3.78M-22.61%35.02M--45.25M------55.56M
Net other financing activities -75.79%-2.22M-112.08%-1.26M-18.73%-596K68.39%-502K---1.59M--------
Cash from discontinued financing activities
Financing cash flow -94.18%10.19M6,047.58%174.96M-91.66%2.85M-20.14%34.12M5,014.34%42.72M-101.59%-869.35K--54.79M
Net cash flow
Beginning cash position 427.88%116.33M-71.73%22.04M74.77%77.95M73.05%44.6M-47.15%25.77M--48.76M----
Current changes in cash -90.87%8.58M258.75%93.99M-269.23%-59.21M84.90%34.99M177.83%18.92M-149.86%-24.31M--48.76M
Effect of exchange rate changes -659.53%-1.67M-90.94%299K301.34%3.3M-1,625.26%-1.64M-107.18%-95K--1.32M----
Cash adjustments other than cash changes ----------------------1.48K----
End cash Position 5.94%123.24M427.88%116.33M-71.73%22.04M74.77%77.95M73.05%44.6M-47.15%25.77M--48.76M
Free cash from 116.82%13.09M-28.29%-77.83M-3,803.72%-60.67M106.88%1.64M-14.71%-23.8M-243.69%-20.75M---6.04M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
AU
Overall
Symbol
Price
% Chg

No Data

Investment Theme Healthcare - Cancer Research
Healthcare - Cancer Research
Intraday+0.01%